C07D 413/00
Heterocyclic compounds containing two or more hetero rings, at least one ring
Official title: Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
C07D413/00 (Heterocyclic compounds containing two or more hetero rings, at least one ring) appears on 18,491 US grants and 22,631 published applications in this corpus.
Search patents in C07D- Granted patents
- 18,491
- Published applications
- 22,631
- Assignees
- 4,456
- Inventors
- 42,144
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 35 | 0 |
| 1977 | 20 | 0 |
| 1978 | 19 | 0 |
| 1979 | 8 | 0 |
| 1980 | 6 | 0 |
| 1981 | 4 | 0 |
| 1982 | 13 | 0 |
| 1983 | 18 | 0 |
| 1984 | 35 | 0 |
| 1985 | 60 | 0 |
| 1986 | 54 | 0 |
| 1987 | 81 | 0 |
| 1988 | 96 | 0 |
| 1989 | 120 | 0 |
| 1990 | 134 | 0 |
| 1991 | 142 | 0 |
| 1992 | 126 | 0 |
| 1993 | 183 | 0 |
| 1994 | 162 | 0 |
| 1995 | 168 | 0 |
| 1996 | 247 | 0 |
| 1997 | 289 | 0 |
| 1998 | 265 | 0 |
| 1999 | 292 | 0 |
| 2000 | 292 | 0 |
| 2001 | 288 | 55 |
| 2002 | 367 | 335 |
| 2003 | 353 | 550 |
| 2004 | 270 | 804 |
| 2005 | 286 | 772 |
| 2006 | 395 | 774 |
| 2007 | 422 | 837 |
| 2008 | 418 | 838 |
| 2009 | 560 | 1035 |
| 2010 | 637 | 1169 |
| 2011 | 632 | 1016 |
| 2012 | 808 | 983 |
| 2013 | 931 | 1037 |
| 2014 | 997 | 1118 |
| 2015 | 945 | 1036 |
| 2016 | 815 | 982 |
| 2017 | 858 | 923 |
| 2018 | 751 | 930 |
| 2019 | 794 | 957 |
| 2020 | 747 | 1056 |
| 2021 | 681 | 879 |
| 2022 | 615 | 880 |
| 2023 | 498 | 1136 |
| 2024 | 510 | 1036 |
| 2025 | 605 | 850 |
| 2026 | 439 | 643 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof6 Oct 2026US 12,753,166 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof6 Oct 2026US 12,753,170 B2Akagera Medicines, Inc.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Trpv4 receptor ligands8 Oct 2026US 2026/0308120 A1University of Utah Research Foundation
- Antidegradant bis(dihydro and tetrahydroquinoline) compounds and uses thereof8 Oct 2026US 2026/0308127 A1Flexsys IP Holdings, LLC
- Triazolyl-containing compounds8 Oct 2026US 2026/0308146 A1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Anthelmintic aza-benzothiophene and aza-benzofuran compounds8 Oct 2026US 2026/0308170 A1Boehringer Ingelheim Vetmedica GmbH
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Pyrimidine derivatives and processes for the preparation thereof595US 5,521,184 ACiba-Geigy Corporation · 1996
- Methods for repairing damaged intervertebral discs571US 6,602,248 B1Arthro Care Corporation · 2003
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010
- Methods for repairing damaged intervertebral discs418US 7,318,823 B2ArthroCare Corporation · 2008